Literature DB >> 8854860

The Lx1 gene maps to mouse chromosome 17 and codes for a protein that is homologous to glucose and polyspecific transmembrane transporters.

N Schweifer1, D P Barlow.   

Abstract

A novel mouse gene, provisionally named Lx1, has been cloned and sequenced. Lx1 most likely represents the mouse homolog of the rat gene OCT1, which encodes a polyspecific transmembrane transporter that is possibly involved in drug elimination. The LX1 predicted protein is highly hydrophobic, possesses twelve putative transmembrane domains, and also shares significant homology with members of the sugar transporter family, particularly the novel liver-specific transporter NLT. Lx1 mRNA is expressed at high levels in mouse liver, kidney, and intestine, and at low levels in the adrenals and in lactating mammary glands. The Lx1 gene maps very close to the imprinted Igf2r/Mpr300 gene on mouse Chromosome (Chr) 17, in a region that is syntenic to human Chr 6q. Chr 6q has been previously associated with transient neonatal diabetes mellitus and breast cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8854860     DOI: 10.1007/s003359900223

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  42 in total

1.  Mammary gland-specific nuclear factor is present in lactating rodent and bovine mammary tissue and composed of a single polypeptide of 89 kDa.

Authors:  H Wakao; M Schmitt-Ney; B Groner
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

2.  Transcription factor MBF-I interacts with metal regulatory elements of higher eucaryotic metallothionein genes.

Authors:  J Imbert; M Zafarullah; V C Culotta; L Gedamu; D Hamer
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

3.  The conserved motif, GXXX(D/E)(R/K)XG[X](R/K)(R/K), in hydrophilic loop 2/3 of the lactose permease.

Authors:  A E Jessen-Marshall; N J Paul; R J Brooker
Journal:  J Biol Chem       Date:  1995-07-07       Impact factor: 5.157

Review 4.  The glucose transporter family: structure, function and tissue-specific expression.

Authors:  G W Gould; G D Holman
Journal:  Biochem J       Date:  1993-10-15       Impact factor: 3.857

5.  Status of the transcription factors database (TFD).

Authors:  D Ghosh
Journal:  Nucleic Acids Res       Date:  1993-07-01       Impact factor: 16.971

6.  Multiple mechanisms of protein insertion into and across membranes.

Authors:  W T Wickner; H F Lodish
Journal:  Science       Date:  1985-10-25       Impact factor: 47.728

7.  The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus.

Authors:  D P Barlow; R Stöger; B G Herrmann; K Saito; N Schweifer
Journal:  Nature       Date:  1991-01-03       Impact factor: 49.962

8.  The mouse plasminogen locus maps to the recombination breakpoints of the tLub2 and TtOrl partial t haplotypes but is not at the tw73 locus.

Authors:  N Schweifer; D P Barlow
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

9.  Multisite phosphorylation of glycogen synthase from rabbit skeletal muscle. Phosphorylation of site 5 by glycogen synthase kinase-5 (casein kinase-II) is a prerequisite for phosphorylation of sites 3 by glycogen synthase kinase-3.

Authors:  C Picton; J Woodgett; B Hemmings; P Cohen
Journal:  FEBS Lett       Date:  1982-12-13       Impact factor: 4.124

10.  Constitutive and IL-6-induced nuclear factors that interact with the human C-reactive protein promoter.

Authors:  B Majello; R Arcone; C Toniatti; G Ciliberto
Journal:  EMBO J       Date:  1990-02       Impact factor: 11.598

View more
  13 in total

1.  Expression of liver plasma membrane transporters in gallstone-susceptible and gallstone-resistant mice.

Authors:  Oliver Müller; Carmen Schalla; Jürgen Scheibner; Eduard F Stange; Michael Fuchs
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

2.  Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene.

Authors:  J W Jonker; E Wagenaar; C A Mol; M Buitelaar; H Koepsell; J W Smit; A H Schinkel
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 3.  Endocrine and metabolic regulation of renal drug transporters.

Authors:  Lindsay L Yacovino; Lauren M Aleksunes
Journal:  J Biochem Mol Toxicol       Date:  2012-08-29       Impact factor: 3.642

4.  Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice.

Authors:  R Zwart; S Verhaagh; M Buitelaar; C Popp-Snijders; D P Barlow
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  Role of organic cation transporter 1, OCT1 in the pharmacokinetics and toxicity of cis-diammine(pyridine)chloroplatinum(II) and oxaliplatin in mice.

Authors:  Shuanglian Li; Ying Chen; Shuzhong Zhang; Swati S More; Xiaozhu Huang; Kathleen M Giacomini
Journal:  Pharm Res       Date:  2010-11-23       Impact factor: 4.200

6.  Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations.

Authors:  Johan W Jonker; Els Wagenaar; Sven Van Eijl; Alfred H Schinkel
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

7.  Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3.

Authors:  Martina Hayer-Zillgen; Michael Brüss; Heinz Bönisch
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

Review 8.  Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug-drug interactions.

Authors:  C Arimany-Nardi; H Koepsell; M Pastor-Anglada
Journal:  Pharmacogenomics J       Date:  2015-11-03       Impact factor: 3.550

Review 9.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

10.  Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics.

Authors:  Y Shu; C Brown; R A Castro; R J Shi; E T Lin; R P Owen; S A Sheardown; L Yue; E G Burchard; C M Brett; K M Giacomini
Journal:  Clin Pharmacol Ther       Date:  2007-07-04       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.